Crossmark

Dual PI3K/mTOR inhibition shows antileukemic activity in MLL-rearranged acute myeloid leukemia

Published Online: 2014-10-17

Published Print: 2015-04

Authors

Sandhöfer, N

Metzeler, K H

Rothenberg, M

Herold, T

Tiedt, S

Groiß, V

Carlet, M

Walter, G

Hinrichsen, T

Wachter, O

Grunert, M

Schneider, S

Subklewe, M

Dufour, A

Fröhling, S

Klein, H-G

Hiddemann, W

Jeremias, I

Spiekermann, K
License Information

Text and Data Mining valid from 2014-10-17

Version of Record valid from 2014-10-17
More Information

Article History

Received: 17 April 2014

Revised: 26 September 2014

Accepted: 2 October 2014

First Online: 17 October 2014

Competing interests

: The authors declare no conflict of interest.

Document is current